(Alliance News) - Life science research software firm Abcam PLC on Friday said it has netted an additional USD23.5 million following exercise of over-allotment options by underwriters of the company's American Depositary share offering.
The underwriters have elected to purchase an additional 1.3 million ADSs at USD17.50 per ADS, raising an additional USD23.5 million and bringing the total gross proceeds of the offering to USD180.0 million.
Earlier in October, the company had launched the ADS offering to list on the Nasdaq Global Market, stating that each ADS offered represents one ordinary share. On Thursday, it had priced its initial public offering of 8.9 million ADS at USD17.50 per share, totalling USD156.5 million.
Morgan Stanley and BofA Securities acted as the lead book-running managers for the ADS offering. SVB Leerink acted as a book-running manager, and Lazard and William Blair acted as co-managers.
Shares in Abcam were down 0.8% at 1,414.00 pence each in London on Friday morning.
By Tapan Panchal; tapanpanchal@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.


(Sharecast News) - RBC Capital Markets downgraded Abcam on Tuesday to 'sector perform' from 'outperform' and cut the price target to $22 from $23 as i...


(Sharecast News) - Online supermarket Ocado was under the cosh on Tuesday after JPMorgan Cazenove cut its price target on the shares to 400p from 450p...


(Sharecast News) - Experts believe that the Bank of England will have to jack up its base rate from 4.5% at present to 5.5% by the end of 2023 in orde...


(Sharecast News) - RBC Capital Markets downgraded Abcam on Tuesday to 'sector perform' from 'outperform' and cut the price target to $22 from $23 as i...


(Sharecast News) - Online supermarket Ocado was under the cosh on Tuesday after JPMorgan Cazenove cut its price target on the shares to 400p from 450p...


(Sharecast News) - Experts believe that the Bank of England will have to jack up its base rate from 4.5% at present to 5.5% by the end of 2023 in orde...


(Sharecast News) - Life science research tool specialist Abcam updated the market on the cancellation of its shares on AIM on Monday, which it first a...


(Alliance News) - Abcam PLC on Monday proposed delisting from AIM in London and retaining a sole listing on Nasdaq in New York.


(Alliance News) - Stocks in London are called a touch lower on Monday, though the pound was on the up, despite the prospect of more UK political uncer...


(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:


Abcam PLC - Cambridge-based life science research software firm - Posts lower profit for six months that ended June 30 as expenses increase. Pretax pr...